by Gorm Pamgren – CRISPR Medicine News –
Researchers have refined prime editing (PE) to correct the cystic fibrosis (CF) related gene CFTR. Results demonstrated improved efficiency and minimal off-target effects in correcting the F508del mutation in human airway epithelial cells and cell lines, leading to results similar to those seen with current CF drug treatments.
